Home

Joshua Reed

CIK 1746541 · SVP, Chief Financial Officer · last filed 2026-07-06

Joshua Reed is a SVP, Chief Financial Officer who has filed 23 SEC Form 4 insider transactions across 4 companies since 2018. The most recent filing shows the insider sold $164.1K of SRRK on Jul 6, 2026. Across all open-market trades the lifetime net is −$309.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.5M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.51M

Companies

4

Total Filings

23

Lifetime Open-Market Net

-$309.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SRRK Director 20,466 $52.64 $1.08M -$324.5K 8 2026-07-06
ALKS SVP, Chief Financial Officer — $48.37 — $0 2 2026-03-04
Omega Therapeutics, Inc. (OMGA) Delisted Chief Financial Officer — $0.14 — $0 4 2024-02-09
ALDX Chief Financial Officer 274,825 $1.59 $437.0K $15.1K 7 2022-04-01

Recent Filings

23 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-06 SRRK Sell (S) −3,053 -$164.1K EDGAR
2026-07-01 SRRK Notice (144) −3,053 -$167.3K EDGAR
2026-06-08 SRRK Grant (A) +6,839 $0 EDGAR
2026-03-04 ALKS Grant (A) — $0 EDGAR
2025-10-10 ALKS Grant (A) — $0 EDGAR
2025-05-30 SRRK Sell (S) −5,400 -$160.5K EDGAR
2025-05-29 SRRK Notice (144) −5,400 -$160.2K EDGAR
2025-05-23 SRRK Grant (A) +7,632 $0 EDGAR
2024-07-01 SRRK Grant (A) +13,500 $0 EDGAR
2024-02-09 Omega Therapeutics, Inc. (OMGA) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 23
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.